Therefore, the signature based on IL1R2, S100A12, and CCL8 may help clinical prediction of prognosis for IPF patients by detecting the expression of these three genes in peripheral blood. The gene discussed is IL1R2; the disease is idiopathic pulmonary fibrosis.